Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia
Survival Analysis in R
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia
The validity of progression‐free survival 2 as a surrogate trial end point for overall survival - Woodford - 2022 - Cancer - Wiley Online Library
Frontiers | Systematic Review and Meta-Analysis of Correlation of Progression-Free Survival-2 and Overall Survival in Solid Tumors
The role of censoring on progression free survival: Oncologist discretion advised - ScienceDirect
Disease-Free Survival As a Clinical Trial Endpoint: Does It Matter, and to Whom?
Progression-free survival (PFS) curve and overall survival (OS) curve... | Download Scientific Diagram
Intermediate clinical endpoints: A bridge between progression‐free survival and overall survival in ovarian cancer trials - Matulonis - 2015 - Cancer - Wiley Online Library
A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine
Progression-Free-Survival (PFS) Analysis in Solid Tumor Clinical Studies
Frontiers | Predicting Progression-Free Survival Using MRI-Based Radiomics for Patients With Nonmetastatic Nasopharyngeal Carcinoma
On Biostatistics and Clinical Trials: Understanding the endpoints in oncology: overall survival, progression free survival, hazard ratio, censored value
Progression-free survival and overall survival curves for all patients... | Download Scientific Diagram
On Biostatistics and Clinical Trials: Understanding the endpoints in oncology: overall survival, progression free survival, hazard ratio, censored value
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project | Blood Cancer Journal
Interpreting overall survival results when progression-free survival b | CMAR
Recurrence-free survival versus overall survival as a primary endpoint for studies of resected colorectal liver metastasis: a retrospective study and meta-analysis - The Lancet Oncology
Background - Progression-Free Survival: What Does It Mean for Psychological Well-Being or Quality of Life? - NCBI Bookshelf
Kaplan-Meier survival curves of progression-free survival and overall... | Download Scientific Diagram
Survival Analysis Basics - Easy Guides - Wiki - STHDA
Progression-Free-Survival (PFS) Analysis in Solid Tumor Clinical Studies
Evaluating Partitioned Survival and Markov Decision-Analytic Modeling Approaches for Use in Cost-Effectiveness Analysis: Estimating and Comparing Survival Outcomes | SpringerLink
Progression Free Survival
